Melior Discovery的封面图片
Melior Discovery

Melior Discovery

制药业

Exton,PA 1,290 位关注者

Capture the Untapped Value of Therapeutics

关于我们

Melior Discovery Inc (Exton, PA, USA) has pioneered a unique “high throughput” in vivo pharmacology platform (theraTRACE?) able to systematically identify novel indications for pre-clinical and development stage drugs. theraTRACE? is widely used by both multinational pharmaceutical and start-up biopharmaceutical companies alike to fully explore the therapeutic potential of their drug candidates. Melior has also leveraged this expertise to build a high quality, onshore, preclinical services capability offering in vivo efficacy models in a broad range of therapeutic areas, pharmacokinetic evaluations, specialized animal models and bioanalytical services to drug developers worldwide.

网站
https://www.meliordiscovery.com
所属行业
制药业
规模
11-50 人
总部
Exton,PA
类型
私人持股
创立
2005
领域
In vivo pharmacology、in vivo models of efficacy、phenotypic screening、drug repurposing、drug repositioning、drug reprofiling、multiplexing、behavioral assays、rodent models of disease、diabetes、Parkinson's Disease和theraTRACE

地点

Melior Discovery员工

动态

相似主页

查看职位

融资

Melior Discovery 共 9 轮

上一轮

未知

US$1,741,599.00

Crunchbase 上查看更多信息